Go to content
UR Home

Estrophilic cisplatin derivatives

Engel, J., Schönenberger, Helmut, Lux, F. and Hilgard, P. (1987) Estrophilic cisplatin derivatives. Cancer treatment reviews 14 (3-4), pp. 275-283.

Full text not available from this repository.


A discussion on cisplatin derivs. for mammary carcinoma therapy is given. Toxicity and metab. are also discussed.

Export bibliographical data

Item type:Article
Additional Information (public):CAN 108:215908 1-6 Pharmacology 15663-27-1 (Cisplatin); 105856-23-3; 105856-32-4; 111086-58-9 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (antitumor activity of, for mammary carcinoma, pharmacol. in relation to); 15663-27-1D (Cisplatin) Role: BIOL (Biological study) (estrophilic, mammary carcinoma growth inhibition by and pharmacol. of)
Institutions:Chemistry and Pharmacy > Institute of Pharmacy > Alumni or Retired Professors > Prof. Schönenberger
Projects:SFB 234
Identification Number:
Keywords:Neoplasm inhibitors (carcinoma, cisplatin derivs. as, for mammary gland) Mammary gland (neoplasm, carcinoma, therapy of, cisplatin derivs. for) carcinoma mammary cisplatin review cisplatin antitumor platinum complex antitumor
Dewey Decimal Classification:500 Science > 540 Chemistry & allied sciences
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:17661
Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons